Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hope you know the 3 indicators (RSI , MACD, MFI )are all telling you the same information. Most likely only one of those is needed. But each person has their own style.
Ok yes I see Gates is a 10% owner and Gates Ventures appears to be a 10% owner. I do not see how Gates acquired his stock, there is no information I can find about if he bought or was awarded the shares somehow. I guess going with what the billionaire is doing may be a good move.
Never made money and no prospects of making money for 5 years at least. Also planning a resale of stock nearly 40 million shares. I will admit I am not sure what this means. How can this be a good investment. Please enlighten me if I am missing a reason to invest here.
"We have not generated any commercial product revenue nor do we expect to generate substantial revenue from product sales unless and until we successfully complete development and obtain regulatory approval for one or more of our therapeutic candidates. Successful therapeutic development and regulatory approval are subject to significant uncertainty and we expect will take at least five years. If we obtain regulatory approval for any of our therapeutic candidates, we expect to incur significant commercialization expenses related to product sales, marketing, manufacturing and distribution. Other sources of revenue could include a combination of research and development payments, license fees and other upfront payments,milestone payments, and royalties in connection with our current and any future collaborations and licenses. Until such time, if ever, that we generate revenue from whatever source, we expect to finance our cash needs through a combination of public or private equity offerings, debt financings and research collaboration and license agreements. We may be unable to raise capital or enter into such other arrangements when needed or on favorable terms. Our failure to raise capital or enter into such other arrangements as and when needed would have a negative impact on our financial condition and our ability to develop our therapeutic candidates."
That is news from 2016. Purdue has since declined further work on the trials. Looks like that product line is put in limbo.
"In April 2018, Purdue has notified the Company it has declined to exercise its option to develop AST-005 at this time, but that it also intends to retain rights relating to the TNF target, and Purdue reserves its right to continue joint development, with Exicure, of new anti-TNF drug candidates and to retain its exclusivity and other rights to AST-005."
Remember reading about this company. The cash flow was way down. Losing money and lots of it. Purdue had dropped the collaboration with the company for I think the psoriasis gel. Just trying to remember with my old brain but it looked like a bad choice to trade, maybe good if investing with a long term hold.
Sorry H2004 I am not paid by anyone. I wish I was. I am only trying to find the true value of the company. Yes only one post but why is that a measure of being a pumper or dumper.
Insider selling 11/16/2017 Joseph P Slattery CFO Sell 529,609 at $2.80 $1,482,905.20 11/14/2017 Joseph P Slattery CFO Sell 333,000 at $2.93 $975,690.00 10/18/2017 Todd Pope Insider Sell 600,000 at $3.68 $2,208,000.00
Dilution possible by corporate officers using cheap warrants.
Joseph Slattery former vice president and chief financial officer of Trans1, renamed Baxano Surgical. Trans1 settled allegations related to Medicare fraud for $6 million and Baxano filed bankruptcy.
The 3 big shots make a combined salary of about $5 million.
Money is going out in big chunks and no sales> They will need to dilute to raise money.
Use the information as you wish it can all be verified in filing if you dig.
Looks like a bad investment. Looking to sell Monday unless someone can provide evidence this company has any chance of success. I bought on several favorable analyst recommendations. Now I find the insiders sold big blocks of stock recently. Company officers gave themselves huge raises. Dilution is continuing by use of warrants held by company officers. Only ever sold 3 units and prospects for selling any in 2018 are dim. Please any backers of this stock wishing to convince me not to sell provide your evidence for holding and quick, Monday is approaching.